HCA Healthcare (HCA)
(Delayed Data from NYSE)
$397.50 USD
-5.93 (-1.47%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $397.50 0.00 (0.00%) 4:18 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$397.50 USD
-5.93 (-1.47%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $397.50 0.00 (0.00%) 4:18 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Zacks News
Here's How Much a $1000 Investment in HCA Healthcare Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Cigna (CI) Unveils Updated Long-Term Growth Targets & Solutions
by Zacks Equity Research
Cigna (CI) currently estimates long-term average annual adjusted EPS growth within 10-14%. It also came up with new solutions to better manage the rising GLP-1 costs and expand behavioral care.
Are Medical Stocks Lagging HCA Healthcare (HCA) This Year?
by Zacks Equity Research
Here is how HCA Healthcare (HCA) and Biotricity Inc. (BTCY) have performed compared to their sector so far this year.
Community Health (CYH), Cost Plus Drugs Unite to Lower Drug Cost
by Zacks Equity Research
Community Health (CYH) collaborates with Cost Plus Drug to reduce drug costs and shortages.
Zacks Investment Ideas feature highlights: Apple, Tesla, HCA Healthcare, DaVita and The Progressive
by Zacks Equity Research
Apple, Tesla, HCA Healthcare, DaVita and The Progressive have been highlighted in this Investment Ideas article.
Market Leaders Rolling Over: Time to Rotate into Defensive Stocks?
by Ethan Feller
Although the stock market has rallied almost nonstop since the start of the year, cracks are beginning to form
Here's Why HCA Healthcare (HCA) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
HCA Healthcare, Inc. (HCA) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
HCA (HCA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks.com featured highlights Iron Mountain, Suzano, Tapestry, HCA Healthcare and W. R. Berkley
by Zacks Equity Research
Iron Mountain, Suzano, Tapestry, HCA Healthcare and W. R. Berkley have been highlighted in this Screen of The Week article.
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Buy 5 High ROE Stocks as Markets Slide on Tech-Sector Woes
by Supriyo Bose
Iron Mountain (IRM), Suzano (SUZ), Tapestry (TPR), HCA Healthcare (HCA) and W. R. Berkley (WRB) are some of the stocks with high ROE to profit from as technology sector drags the broader index down.
Ensign Group (ENSG) Buys Nursing Units, Boosts U.S. Footprint
by Zacks Equity Research
Ensign Group (ENSG) acquires two skilled nursing facilities in Colorado and one similar facility in Kansas to better serve the regions' patients and grow its healthcare portfolio.
HCA Healthcare (HCA) Rises 24.8% in a Year: More Room to Run?
by Zacks Equity Research
HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services and Tenet Healthcare
by Zacks Equity Research
HCA Healthcare, Universal Health Services and Tenet Healthcare have been highlighted in this Industry Outlook article.
Why the Market Dipped But HCA Healthcare (HCA) Gained Today
by Zacks Equity Research
The latest trading day saw HCA Healthcare (HCA) settling at $314.08, representing a +0.67% change from its previous close.
3 Stocks Worth a Deeper Dive in the Thriving Hospital Industry
by Kaibalya Pravo Dey
Following a careful analysis of the Zacks Medical-Hospital industry, we advise focusing on companies like HCA, UHS and THC.
Tenet Healthcare (THC) to Sell Hospitals to Refine Portfolio
by Zacks Equity Research
Tenet Healthcare (THC) enters an agreement with Adventist Health to divest two of THC's hospitals, and continue to make Conifer's revenue cycle management services available for the divested operations.
Can This U.S. "AI" Boom Override Geopolitics?
by John Blank
An Aggressive Posture on Asset Allocation Can Remain Attractive.
Why Is HCA (HCA) Up 2.4% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Buy HCA Healthcare (HCA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HCA Healthcare (HCA) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
HCA Healthcare (HCA) reachead $313.20 at the closing of the latest trading day, reflecting a -0.68% change compared to its last close.
Is It Worth Investing in HCA (HCA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), HCA (HCA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HCA Healthcare (HCA) Drives Efficiency With New Outpatient Model
by Zacks Equity Research
HCA Healthcare's (HCA) Sarah Cannon Cancer Institute adopts a new outpatient model for CAR T-cell therapy patients.
Here's Why HCA Healthcare (HCA) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.